Clinical Trial Update: Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis [NA]

View source ↗

Summary

A multicenter randomized cross-over clinical trial compares the DialogiQ biologic fusion option to standard haemodialysis in hypotension-prone patients on maint…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: B.Braun Avitum AG | Conditions: Renal Dialysis | NA | Status: RECRUITING